These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10230612)

  • 1. Design and synthesis of potent and selective 5,6-fused heterocyclic thrombin inhibitors.
    Dominguez C; Duffy DE; Han Q; Alexander RS; Galemmo RA; Park JM; Wong PC; Amparo EC; Knabb RM; Luettgen J; Wexler RR
    Bioorg Med Chem Lett; 1999 Apr; 9(7):925-30. PubMed ID: 10230612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of inhibitors derived from 3-amidinophenylalanine.
    Stürzebecher J; Prasa D; Wikström P; Vieweg H
    J Enzyme Inhib; 1995; 9(1):87-99. PubMed ID: 8568569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterocyclic thrombin inhibitors. Part 1: design and synthesis of amidino-phenoxy quinoline derivatives.
    Ries UJ; Priepke HW; Hauel NH; Haaksma EE; Stassen JM; Wienen W; Nar H
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2291-5. PubMed ID: 12824020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular recognition at the thrombin active site: structure-based design and synthesis of potent and selective thrombin inhibitors and the X-ray crystal structures of two thrombin-inhibitor complexes.
    Obst U; Banner DW; Weber L; Diederich F
    Chem Biol; 1997 Apr; 4(4):287-95. PubMed ID: 9195869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting subsite S1 of trypsin-like serine proteases for selectivity: potent and selective inhibitors of urokinase-type plasminogen activator.
    Mackman RL; Katz BA; Breitenbucher JG; Hui HC; Verner E; Luong C; Liu L; Sprengeler PA
    J Med Chem; 2001 Nov; 44(23):3856-71. PubMed ID: 11689072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-covalent thrombin inhibitors featuring P(3)-heterocycles with P(1)-monocyclic arginine surrogates.
    Reiner JE; Siev DV; Araldi GL; Cui JJ; Ho JZ; Reddy KM; Mamedova L; Vu PH; Lee KS; Minami NK; Gibson TS; Anderson SM; Bradbury AE; Nolan TG; Semple JE
    Bioorg Med Chem Lett; 2002 Apr; 12(8):1203-8. PubMed ID: 11934589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.
    Mack H; Pfeiffer T; Hornberger W; Böhm HJ; Höffken HW
    J Enzyme Inhib; 1995; 9(1):73-86. PubMed ID: 8568568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
    Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
    J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of potent and selective amidino bicyclic factor Xa inhibitors.
    Han Q; Dominguez C; Stouten PF; Park JM; Duffy DE; Galemmo RA; Rossi KA; Alexander RS; Smallwood AM; Wong PC; Wright MM; Luettgen JM; Knabb RM; Wexler RR
    J Med Chem; 2000 Nov; 43(23):4398-415. PubMed ID: 11087565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-peptidic phenyl-based thrombin inhibitors: exploring structural requirements of the S1 specificity pocket with amidines.
    Lu T; Tomczuk B; Bone R; Murphy L; Salemme FR; Soll RM
    Bioorg Med Chem Lett; 2000 Jan; 10(1):83-5. PubMed ID: 10636250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor.
    Young RJ; Alderton W; Angell AD; Beswick PJ; Brown D; Chambers CL; Crowe MC; Dawson J; Hamlett CC; Hodgson ST; Kleanthous S; Knowles RG; Russell LJ; Stocker R; Woolven JM
    Bioorg Med Chem Lett; 2011 May; 21(10):3037-40. PubMed ID: 21482467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Design, synthesis and 5-HT/NE dual reuptake inhibitory activity of aromatic heterocyclic arylamidine derivatives].
    Wen H; Yang J; Zhang JJ; Wang YF; Ji CX; Yang GZ
    Yao Xue Xue Bao; 2009 Mar; 44(3):303-8. PubMed ID: 19449528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterocyclic core analogs of a direct thrombin inhibitor.
    Blizzard TA; Singh S; Patil B; Chidurala N; Komanduri V; Debnath S; Belyakov S; Crespo A; Struck A; Kurtz M; Wiltsie J; Shen X; Sonatore L; Arocho M; Lewis D; Ogletree M; Biftu T
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1111-5. PubMed ID: 24461292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of potent and highly selective thrombin inhibitors.
    Hilpert K; Ackermann J; Banner DW; Gast A; Gubernator K; Hadváry P; Labler L; Müller K; Schmid G; Tschopp TB
    J Med Chem; 1994 Nov; 37(23):3889-901. PubMed ID: 7966150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists.
    Hategan G; Polozov AM; Zeller W; Cao H; Mishra RK; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6797-800. PubMed ID: 19836233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2.
    Cody WL; Augelli-Szafran CE; Berryman KA; Cai C; Doherty AM; Edmunds JJ; He JX; Narasimhan LS; Penvose-Yi J; Plummer JS; Rapundalo ST; Rubin JR; Van Huis CA; Leblond L; Winocour PD; Siddiqui MA
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2503-8. PubMed ID: 10498197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Pot Two-Step Multicomponent Process of Indole and Other Nitrogenous Heterocycles or Amines toward α-Oxo-acetamidines.
    Martinez-Ariza G; McConnell N; Hulme C
    Org Lett; 2016 Apr; 18(8):1864-7. PubMed ID: 27020621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 1.
    Cody WL; Cai C; Doherty AM; Edmunds JJ; He JX; Narasimhan LS; Plummer JS; Rapundalo ST; Rubin JR; Van Huis CA; St-Denis Y; Winocour PD; Siddiqui MA
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2497-502. PubMed ID: 10498196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional and microwave assisted synthesis of small molecule based biologically active heterocyclic amidine derivatives.
    Sondhi SM; Rani R; Roy P; Agrawal SK; Saxena AK
    Eur J Med Chem; 2010 Mar; 45(3):902-8. PubMed ID: 19959259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active site-directed thrombin inhibitors--II. Studies related to arginine/guanidine bioisosteres.
    St Laurent DR; Balasubramanian N; Han WT; Trehan A; Federici ME; Meanwell NA; Wright JJ; Seiler SM
    Bioorg Med Chem; 1995 Aug; 3(8):1145-56. PubMed ID: 7582986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.